Picropodophyllin Completed Phase 2 Trials for Adenocarcinoma of the Lung / Non-Small Cell Lung Cancer (NSCLC) / Squamous Cell Carcinoma (SCC) Treatment

Indications	Status	Purpose	Phase
DBCOND0028475 (Adenocarcinoma of the Lung) DBCOND0034130 (Non-Small Cell Lung Cancer (NSCLC)) DBCOND0043488 (Squamous Cell Carcinoma (SCC))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01561456	Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung	Docetaxel (DB01248) Picropodophyllin (DB12802)